# Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-in-patients-with-advanced-endometrial-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Vicky Makker,Matthew H. Taylor,Carol Aghajanian,Ana Oaknin,James W. Mier,Allen Lee Cohn,Margarita Romeo,Raquel Bratos,Marcia S. Brose,Christopher DiSimone,Mark Messing,Daniel E. Stepan,Corina E. Dutcus,Jane Wu,Emmett V. Schmidt,Robert Orlowski,Pallavi Sachdev,Robert Shumaker,Antonio Casado |
| Citations | 525 |
| DOI | 10.1200/jco.19.02627 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.19.02627 |
| OpenAlex ID | https://openalex.org/W3011919019 |
| PMID | 32167863 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Carol Aghajanian](https://scholariq.org/researchers/carol-aghajanian/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.